Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
Type:
Grant
Filed:
April 11, 2022
Date of Patent:
September 12, 2023
Assignee:
COHBAR, INC.
Inventors:
Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan
Abstract: A formulation comprising glutamic acid, or a salt thereof, and an effective amount of a peptide is provided. The invention also provides a method of preparing the formulation, methods of treating a condition using the formulation, and a kit containing components of the formulation. The invention further provides a sustained release formulation for drug substances comprising glutamic acid, or a salt thereof, and an amount of a peptide.
Type:
Grant
Filed:
March 27, 2019
Date of Patent:
December 6, 2022
Assignee:
COHBAR, INC.
Inventors:
Kenneth Cundy, Kent K. Grindstaff, Remi Magnan
Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
Type:
Grant
Filed:
August 4, 2021
Date of Patent:
May 17, 2022
Assignee:
COHBAR, INC.
Inventors:
Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
Type:
Grant
Filed:
September 27, 2017
Date of Patent:
September 7, 2021
Assignee:
COHBAR, INC.
Inventors:
Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan